BlockBeats news, on July 18, the official information disclosure system of the Hong Kong Stock Exchange showed that on July 17, Huajian Medical (01931.HK) announced the official launch of the 'IVDNewCo Exchange' ecosystem plan, introducing the world's first RWA trading platform ecosystem focused on medical innovative drugs NewCo high-tech assets and the accompanying issuance of the IVDD stablecoin plan.
It is reported that the company is actively promoting a milestone strategic initiative to build a 'NewCo + RWA + Web3' trading platform ecosystem centered on high-tech assets for medical innovative drugs, which will be named 'IVDNewCo Exchange' and will issue a proprietary stablecoin (IVDDollar 'IVDD').
This strategy aims to disrupt the traditional rules of the pharmaceutical industry by integrating Web3 technology (including RWA tokenization of real-world assets, blockchain trading, and stablecoin mechanisms) to enhance the liquidity, financing efficiency, and accessibility of global medical innovative drug assets. The following will elaborate on the strategic concept, progress, advantages, and future plans of this ecosystem.
